{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T07:35:19Z","timestamp":1747208119786,"version":"3.40.5"},"reference-count":13,"publisher":"Informa UK Limited","issue":"sup1","funder":[{"name":"Eisai"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncol."],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.2217\/fon-2019-0597","type":"journal-article","created":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T14:33:02Z","timestamp":1578580382000},"page":"15-19","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Response to Eribulin in a Patient with Metastatic Uterine Leiomyosarcoma: A Case Report"],"prefix":"10.1080","volume":"16","author":[{"given":"Sandra","family":"Aliberti","sequence":"first","affiliation":[{"name":"Division of Medical Oncology,Candiolo Cancer Institute, FPO-IRCCS,\rCandiolo (TO),\rItaly"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Miano","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology,Candiolo Cancer Institute, FPO-IRCCS,\rCandiolo (TO),\rItaly"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Tolomeo","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology,Candiolo Cancer Institute, FPO-IRCCS,\rCandiolo (TO),\rItaly"},{"name":"Department of Oncology,University of Torino,\rTorino,\rItaly"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Merlini","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology,Candiolo Cancer Institute, FPO-IRCCS,\rCandiolo (TO),\rItaly"},{"name":"Department of Oncology,University of Torino,\rTorino,\rItaly"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Aglietta","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology,Candiolo Cancer Institute, FPO-IRCCS,\rCandiolo (TO),\rItaly"},{"name":"Department of Oncology,University of Torino,\rTorino,\rItaly"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5515-569X","authenticated-orcid":false,"given":"Giovanni","family":"Grignani","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology,Candiolo Cancer Institute, FPO-IRCCS,\rCandiolo (TO),\rItaly"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2020,1,9]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2017.02.019"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.3109\/0284186X.2012.689111"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-008-0422-2"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.19.8366"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70063-4"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2003.11.023"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60651-5"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.21.0088"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.33.6107"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2015.33.18_suppl.lba10502"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01283-0"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-019-0462-1"},{"issue":"5","key":"e_1_3_4_15_1","article-title":"1683P. One-year follow-up results of eribulin for soft-tissue sarcoma including rare subtypes in a real-world observational study in Japan","volume":"30","author":"Takahashi S","year":"2019","unstructured":"Takahashi S , MegumiY, SakataY, IkezawaH, MatsuokaT, KawaiA. 1683P. One-year follow-up results of eribulin for soft-tissue sarcoma including rare subtypes in a real-world observational study in Japan. Ann. Oncol.30(5s), mdz283.016 (2019).","journal-title":"Ann. Oncol."}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fon-2019-0597","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:45:59Z","timestamp":1719125159000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fon-2019-0597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":13,"journal-issue":{"issue":"sup1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["10.2217\/fon-2019-0597"],"URL":"https:\/\/doi.org\/10.2217\/fon-2019-0597","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"type":"print","value":"1479-6694"},{"type":"electronic","value":"1744-8301"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2019-09-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-06","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}